Clinical Trial Update: Immediate Release (IR) to Sustained Release (SR) Switching Study: Study of Switching From IR Seroquel to SR Seroquel in Outpatients With Schizophrenia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update indicates the completion of a study evaluating switching outpatients with schizophrenia from immediate-release Seroquel to susta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• SEROQUEL (QUETIAPINE)

Snippet

Sponsor: AstraZeneca | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED